NARA Discovery
Article Details
← Back to Search Results
Journal Article

The novel anti-migraine compound zolmitriptan (Zomig 311C90) has no clinically significant interactions with paracetamol or metoclopramide

E. J. Seaber; G. Ridout; G. Layton; J. Posner; R. W. Peck
European Journal of Clinical Pharmacology · Vol. 53, Issue 3-4 · pp. 229-234 · 1997

Abstract

Abstract is unavailable.

Bibliographic Information

JournalEuropean Journal of Clinical Pharmacology
PublisherSpringer
Publication Date1997-12-15
Publication Year1997
Volume53
Issue3-4
Pages229-234
Document TypeJournal Article
Print ISSN0031-6970
eISSN1432-1041
DOI10.1007/s002280050367

Access Information

NARA Access Coverage1968-01-01~Current
Journal Homepagehttps://www.springer.com/journal/228
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.